AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard
A New Chapter for Squamous Cell Lung Cancer: Harmoni’s Breakthrough at ASCO 2026
Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success